Larimar Therapeutics, Inc. LRMR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-19
Larimar Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Flynn James E | director | 2026-02-27 | Buy | 1,084,010 | $5.00 |
| Flynn James E | director | 2026-02-27 | Buy | 1,084,012 | $5.00 |
| Flynn James E | director | 2026-02-27 | Buy | 831,978 | $5.00 |
| Flynn James E | director | 2026-02-27 | Buy | 2,000,000 | $5.00 |
| Hamilton Thomas Edward | director | 2026-02-27 | Buy | 100,000 | $5.00 |
| THOMAS FRANK E | director | 2026-02-27 | Buy | 5,000 | $5.00 |
| SHERMAN JEFFREY W | director | 2026-02-27 | Buy | 5,000 | $5.00 |
Source: SEC EDGAR filings · CIK 0001374690 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.